2021
Cardiac allograft vasculopathy: current review and future research directions
Pober JS, Chih S, Kobashigawa J, Madsen JC, Tellides G. Cardiac allograft vasculopathy: current review and future research directions. Cardiovascular Research 2021, 117: 2624-2638. PMID: 34343276, PMCID: PMC8783389, DOI: 10.1093/cvr/cvab259.Peer-Reviewed Original ResearchConceptsCardiac allograft vasculopathyAllograft vasculopathyImmune-mediated vasculopathyLate graft lossGraft lossCardiac transplantationOrgan graftsTransplanted heartsCurrent therapiesVascular remodellingVasculopathyMajor causeCurrent reviewRemodellingTransplantationPathogenesisGraftTherapyPerfusionIncidenceDiagnosisVasculature
1983
Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon
Pober J, Collins T, Gimbrone M, Cotran R, Gitlin J, Fiers W, Clayberger C, Krensky A, Burakoff S, Reiss C. Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature 1983, 305: 726-729. PMID: 6415484, DOI: 10.1038/305726a0.Peer-Reviewed Original ResearchConceptsCytolytic T lymphocytesRecombinant immune interferonIa antigensT cellsIa expressionAlloreactive cytolytic T lymphocytesClass II major histocompatibility complex antigensT-lymphocyte-mediated responsesImmune interferonEndothelial cellsMajor histocompatibility complex antigensForeign class IHistocompatibility complex antigensHuman vascular endothelialHuman umbilical vein endothelial cellsHUVE cellsCapillary endothelial cellsUmbilical vein endothelial cellsHuman T cellsImmunological cell typesAllograft rejectionVein endothelial cellsOrgan graftsT lymphocytesComplex antigens